Louisiana musician diagnosed with prostate cancer at 33 after wife pushed him to see a doctor

By Marissa George
updated on September 23, 2026

A 33-year-old musician walked into a routine physical to prove he was healthy, and walked out with a prostate cancer diagnosis that current screening guidelines would never have caught.

Joseph Wayne Singleton, frontman of The Urban Kreyol Band and a lifelong resident of Opelousas, Louisiana, had no symptoms. No family history of cancer. No reason to worry. His wife, Ashley, had simply grown tired of watching him rely on the basic exams required to keep his commercial driver's license and insisted he get a real checkup.

Singleton went along to keep the peace. As he told Fox News Digital, his attitude was straightforward: "My mentality was, 'OK, to make my wife happy, I'm going to do this and prove to her that I'm in perfect shape.'"

He was not in perfect shape. His doctor, for reasons even the physician could not explain, ordered a PSA blood test, a prostate-specific antigen screening that measures protein levels in the blood and can flag cancer. At 33, Singleton was years younger than the age at which most guidelines recommend screening even begin. The results came back, in Singleton's words, "through the roof."

A biopsy confirmed the worst. Singleton had prostate cancer, a disease the American Cancer Society describes as uncommon in men younger than 40.

No symptoms, no risk factors, no explanation

Robert Smith, Ph.D., senior vice president of cancer screening at the American Cancer Society in Atlanta, reviewed the case for Fox News Digital. Smith noted that Singleton's diagnosis was particularly alarming because the musician was in his early 30s, showed no symptoms, and had no known risk factors.

Current screening guidelines vary by organization, but most recommend that average-risk men begin discussing PSA testing with their doctors between ages 45 and 55. Higher-risk men, including Black men and those with a family history of cancer, are advised to start screening between 40 and 45. Singleton fell below every threshold.

Smith emphasized that the medical consensus has shifted in recent years. As he put it:

"Over this period, it has become clear that prostate cancer screening is more effective at reducing prostate cancer deaths than was previously believed, and there are new strategies... to mitigate the harms associated with diagnosing and treating prostate cancer."

Still, most major organizations stop short of issuing blanket screening orders. Smith said the prevailing approach is for clinicians to discuss the benefits, limitations, and potential harms of screening with patients, not to mandate it.

That cautious posture means men like Singleton, who fall outside the standard risk profile, can slip through. Without a wife who pushed him and a doctor who followed an instinct he could not articulate, Singleton's cancer would have gone undetected.

Singleton was back on tour within weeks of surgery

After his diagnosis, Singleton traveled to UT MD Anderson Cancer Center in Houston, one of the nation's top cancer hospitals, for treatment. Surgeons performed a prostatectomy, the full removal of the prostate gland.

The recovery was faster than he expected. Singleton told Fox News Digital he was back on airplanes and performing with his band just a couple of weeks after surgery:

"A couple of weeks after having the prostatectomy, I was back on airplanes flying across the country doing shows with my band. It wasn't as bad as it possibly could have been."

Now 45, Singleton looks back on the experience with a mix of gratitude and lingering disbelief. "By the grace of God, I'm here now," he said. "It was quite an eye-opener. It made me question myself... a lot of 'why me?'"

He does not dwell on that question anymore. Singleton said he arrived at an answer: his platform as a touring musician gave him a way to reach people who might otherwise skip a doctor's visit the way he nearly did.

A musician's platform turned into a public health message

Singleton has since made prostate cancer awareness a personal cause. He said people from across the country have contacted him after learning about his story, and he sees the outreach as validation that the message matters.

"I came to the conclusion that because of the platform that I have, being a musician, that maybe it was meant for me to be an advocate. I'm having people reach out to me from all across the country [who are] finding out about my story... and I think it's very important."

His core argument is simple and hard to dispute: early testing saved his life, and waiting for symptoms could have cost it. "This could have turned out so much worse had I not gotten tested early," Singleton said. "I hate to think what could have happened."

Smith, the American Cancer Society screening expert, reinforced the broader point. "Regular PSA testing can reduce the risk associated with being diagnosed with an advanced prostate cancer," he said. He also noted that lifestyle choices, maintaining a healthy weight, exercising, eating well, can lower cancer risk alongside cardiovascular disease and diabetes risk.

On one widely discussed theory, that staying sexually active might reduce prostate cancer risk, Smith offered a measured assessment: "Some studies have suggested that staying sexually active can lower risk, but results are mixed."

Guidelines built for populations can miss individuals

Screening guidelines exist for good reason. Mass screening of young, low-risk men can lead to unnecessary biopsies, overtreatment, and serious side effects. Smith acknowledged as much when he described the ongoing effort to balance the benefits of early detection against the harms of aggressive intervention.

But Singleton's case illustrates the blind spot. Population-level guidelines are designed to serve the average patient. They are not designed to catch the 33-year-old with no symptoms and no family history whose PSA levels are, by his own account, off the charts. That gap exists because medicine cannot yet explain why some young men develop a disease that overwhelmingly strikes older populations.

Singleton's unnamed doctor could not explain why he ordered the test. Singleton cannot explain why he got cancer. The American Cancer Society cannot yet recommend universal screening for men that young. What everyone involved can agree on is that the test caught something that would otherwise have grown silently worse.

Singleton framed his mission in the plainest terms: "If I could help prevent somebody else from going through what I might have gone through, worse than what I went through, that's the main goal."

Sometimes the best medical advice comes not from a guideline but from a spouse who refuses to take "I'm fine" for an answer.

About Marissa George

Marissa is a staff writer for Real Talk Digest. She is en expert in breaking down the political boondoggle into the real facts for real people.

Real Talk. Daily.

No spin. No fluff. Just the hard truth. served straight. Every morning, we cut through the noise and deliver what really matters to hardworking Americans. No agendas. No media games. Just real talk you can trust.